Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to ...
Researchers gain new insights into how the isotope astatine-211 interacts with resins commonly used to purify the isotope for therapeutic use Targeted Alpha Therapy (TAT) is one of the most powerful ...
In research, published in Chemical Engineering Journal, scientists design and test an automated device aimed at remote dissolution of an irradiated bismuth target followed by extraction chromatography ...
TOKYO--(BUSINESS WIRE)--Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the ...
Concept of the automated system for remote dissolution of the irradiated bismuth target and astatine recovery in nitric acid media. Astatine-211 (At-211) is one of a handful of promising alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results